...Miraca’s Miraca Life Sciences subsidiary launched in the U.S. four assays derived from Theradiag’s Lisa Tracker...
...disclose financial terms (see BioCentury, Dec. 21, 2015). Theradiag S.A. (Euronext:ALTER), Marne La Vallee, France Miraca Holdings Inc....

...Theradiag granted Miraca’s Miraca Life Sciences subsidiary exclusive, U.S. rights to develop and commercialize Lisa Tracker...
...Miraca Life Sciences also has an option to license additional Lisa Tracker technologies. In 1Q16, Miraca...
...U.S. The partners declined to disclose financial terms. Theradiag S.A. (Euronext:ALTER), Marne La Vallee, France Miraca Holdings Inc....

...Oxford Gene Technology granted Baylor College of Medicine’s Baylor Miraca Genetics Laboratories rights to single nucleotide...

...MDxHealth granted Miraca’s Miraca Life Sciences Inc. subsidiary non-exclusive, co-promotion rights in the U.S. to MDxHealth’s...
...Inc. subsidiary non-exclusive, co-promotion rights in the U.S. to MDxHealth’s ConfirmMDx for Prostate Cancer test. Miraca...
...tissue, ruling out healthy men from undergoing unnecessary repeat biopsies. MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Miraca Holdings Inc....

...Holding company Miraca completed its acquisition of the anatomic pathology business operated by Caris' Caris Diagnostics...
...Carisome circulating microvesicle technology (see BioCentury, Oct. 17). Caris Life Sciences Inc. , Irving, Texas Miraca Holdings Inc....

...Holding company Miraca will acquire the anatomic pathology business operated by Caris' Caris Diagnostics Inc. subsidiary...
...Carisome circulating microvesicle technology. Terms were not disclosed. Caris Life Sciences Inc. , Irving, Texas Miraca Holdings Inc....

...a Miraca Holdings company, acquired Innogenetics in September. GenMark Diagnostics Inc. (NASDAQ:GNMK), Pasadena, Calif. Miraca Holdings Inc....